Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Intrauterine Administration of Autologous Peripheral Blood Mononuclear Cells (PBMC) Modulated With Interferon Tau (IFNt) on Endometrial Cell Populations

NCT05775211 is registered in ClinicalTrials.gov with Nadezhda Women's Health Hospital as lead sponsor.

NCT NCT05775211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05775211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Intrauterine Administration of Autologous Peripheral Blood Mononuclear Cells (PBMC) Modulated With Interferon Tau (IFNt) on Endometrial Cell Populations
Lead sponsor
Nadezhda Women's Health Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 13, 2023
Completion date
April 28, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility